IPG Investment Advisors LLC Sells 1,822 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

IPG Investment Advisors LLC lessened its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 51.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,741 shares of the biotechnology company’s stock after selling 1,822 shares during the quarter. IPG Investment Advisors LLC’s holdings in Axon Enterprise were worth $1,035,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Prestige Wealth Management Group LLC increased its position in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the period. New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise during the fourth quarter valued at $40,000. Brooklyn Investment Group acquired a new stake in Axon Enterprise during the 3rd quarter worth about $41,000. Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise in the 4th quarter worth about $45,000. Finally, Stonebridge Financial Group LLC acquired a new position in shares of Axon Enterprise in the 4th quarter valued at about $53,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 2.9 %

AXON opened at $534.95 on Friday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The firm has a market capitalization of $40.99 billion, a P/E ratio of 138.23, a PEG ratio of 5.17 and a beta of 1.12. The company’s 50-day moving average is $589.62 and its 200 day moving average is $549.29. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on AXON. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $604.67.

Insider Buying and Selling at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.